DRL's R&D spend at 15% of net sales in '05
Drug companies are pouring funds into
R&D both in India and abroad. Ranbaxy, Cipla, Dr Reddy's
Laboratories, Nicholas Piramal and Sun Pharma's research
and development expenses have increased from Rs 585
crore in FY04 to Rs 859 crore in FY05, a 47% increase
in a single year.
September 21, 2005